Kristen Fortney, co-founder and CEO of BioAge Labs
December 3, 2020 10:36 AM ESTUpdated 11:11 AM
Financing
R&D

A high-pro­file ‘an­gel’ joins the Sil­i­con Val­ley crew back­ing an an­ti-ag­ing up­start with an eye on PhII

Max Gelman

Senior Editor

Sil­i­con Val­ley’s mis­sion to con­quer ag­ing rages on, as two high-pro­file VCs are lead­ing a new Se­ries C in the field.

BioAge Labs, a Rich­mond …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
TRENDING NOW

Trump taps Johns Hop­kins re­searcher Mar­ty Makary to lead the FDA; al­so names CDC, sur­geon gen­er­al picks

Drug or bi­o­log­ic? An Eli Lil­ly law­suit could im­pact weight loss drug com­pounders

FDA ap­proves Bridge­Bio's heart dis­ease drug, set­ting up com­pe­ti­tion with Pfiz­er, Al­ny­lam

From vac­cines to psy­che­delics, five drug­mak­ers on what could change un­der a Trump ad­min­is­tra­tion

Sanofi in­tro­duces new 340B pay­ment mod­el — re­port

Pa­tient dies in Neu­ro­gene's Rett syn­drome study

A service from the Financial Times